Company Ticker News January 19, 2022ChemoCentryx's Avacopan Scores European Approval For ANCA-Associated Vasculitis 0 0 Share
Company Ticker News October 8, 2021Why Did ChemoCentryx Shares Soar 70% On Friday Premarket? 0 0 Share
Press Release October 8, 2021ChemoCentryx Announces FDA Approval of TAVNEOS™ (avacopan) in ANCA-Associated Vasculitis 0 0 Share